United States · FDA National Drug Code directory
Ropivacaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-066_79b226f0-c08a-4f84-bf2b-ae5c60e01d67
- Product NDC
- 70069-066
- Form
- INJECTION
- Composition / generic term
- Ropivacaine Hydrochloride
- Labeler
- Somerset Therapeutics, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180615
- Source listing expiry
- 20261231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (70069-066-10) / 10 mL in 1 VIAL (70069-066-01) · 70069-066-10
- 25 VIAL in 1 VIAL (70069-066-25) / 10 mL in 1 VIAL (70069-066-01) · 70069-066-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →